摘要
血管内皮生长因子在骨肉瘤血管生长中起着关键的调节作用,并参与骨肉瘤细胞凋亡,与肿瘤的免疫和耐药有关。在治疗中,不应忽视其在骨肉瘤的发生、发展、浸润及转移中的重要作用。
参考文献17
-
1Ferguson WS.Gnnnn AM.Cancer Invest.200l:19(3):292～315.
-
2Ruhrberg C.Gerhardt H.Golding M,et al.Genes Dev,2002；16(20):2684～2698.
-
3Lee YH.Tokunaga T.Oshika Y,et al.Eur J Cancer·1999；35(7):1089～1093.
-
4Handa A.Tokunaga T,Tsuchida T,et al.Int J Oncol·2000；17(2):291～295.
-
5Vaux EC.Metzen E.Yeates KM,et al.Blood.2001；98(2):296～302.
-
6Salimath B.Marme D,Finkenzeller G.Oncogene.2000；19(31):3470~3476.
-
7Esbrit P,Alvarez—Arroyo MV,de Miguel F,et al.J Am Soc Nephrol,2000；11(6):1085～1092.
-
8Schlaeppi JM.Gutzwiller S.Finkenzeller G,et al.Endocr Res·1997:23(3):213～219.
-
9Holzer G,Obermair A,Koschat M.et al.Med Pediatr Oncol、2001:36(6):601～604.
-
10Kaya M.Wada T,Kawaguchi S,et al.Br J Cancer,2002；86(6):864～869.
同被引文献11
-
1Hess AR.VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway:implications for vasculogenic mimicry[J].Cancer Biol Ther,2006,5(2):228-233.
-
2Santini MT.MG-63 human osteosarcoma cells grown in monolayer and as three-dimensional tumor spheroids present a different metabolic profile:a (1) H NMR study[J].FEBS Lett,2004,557(1-3):148-154.
-
3Rainaldi G,Ferrante A,Indovina PL,et al.Induction of apoptosis or necrosis by ionizing radiation is dose-dependent in MG-63 osteosarcoma multicellular spheroids[J].Anticancer Res,2003,23 (3B):2505-2518.
-
4Ritty TM.Tendon cells produce gelatinases in response to type Ⅰ collagen attachment[J].J Orthop Res,2003,21(3):442-450.
-
5Lyden D,Hattori K,Dias S,et al.Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks rumor angiogenesis and growth[J].Nat Med,2001,7(11):1194-1201.
-
6Auguste P,Lemiere S,Larrieu-Lahargue F,et al.Molecular mechanisms of tumor vascularization[J].Crit Rev Oncol Hematol,2005,54 (1):53-61.
-
7Maniotis AJ,Folberg R,Hess A,et al.Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry[J].Am J Pathol,1999,155 (3):739-752.
-
8Seftor EA,Meltzer PS,Schatteman GC,et al.Expression of multiple molecular phenotypes by aggressive melanoma tumor cells:role in vasculogenic mimicry[J].Crit Rev Oncol Hematol,2002,44:17-27.
-
9Sood AK,Seftor EA,Fletcher MS,et al.Molecular determinants of ovarian cancer plasticity[J].Am J Pathol,2001,158:1279-1288.
-
10Sood AK,Fletcher MS,Hendrix MJ.The embryonic-like properties of aggressive human tumor cells[J].J Soc Gynecol Investig,2002,9:2-9.
二级引证文献5
-
1毕刚,王家骐,胡牧,薛华明,钱光,梅炯.骨肉瘤标本血管铸形观察[J].同济大学学报（医学版）,2007,28(3):16-19.
-
2张立智,蔡宣松,钱志康,梅炯,马小辉,黄煌渊,黄伟达.EPHA2-siRNA质粒对骨肉瘤细胞生物学行为的影响[J].中华肿瘤杂志,2007,29(8):566-569. 被引量：6
-
3张立智,蔡宣松,钱志康,梅炯,黄煌渊,黄伟达.VEGF特异siRNA对骨肉瘤细胞凋亡和仿血管发生的影响[J].中国肿瘤生物治疗杂志,2007,14(4):352-356. 被引量：7
-
4张培根,王栓科,康学文,夏亚一,汪静,韩兴文.赛来昔布对人骨肉瘤类肿瘤干细胞移植瘤微血管生成的影响[J].中国矫形外科杂志,2009,17(1):59-62. 被引量：7
-
5孙佼,张春林,吴小三,赵世昌,赵曜,曾炳芳.MG63和MG63/ADR骨肉瘤裸鼠模型血管内皮生长因子和核因子κB1的表达[J].中国组织工程研究与临床康复,2011,15(41):7653-7656.
-
1朱洪新,李锦军,万大方.单克隆抗体在肿瘤抗血管新生治疗策略中的研究进展[J].肿瘤,2002,22(3):248-249.
-
2夏加增,尹浩然,朱正纲.肿瘤抗血管新生治疗的策略[J].临床肿瘤学杂志,1999,4(3):76-77. 被引量：1
-
3崔凤东,吴孟超,喻德洪,磨伊正羲.抗血管新生疗法治疗大肠癌肝转移[J].大肠肛门病外科杂志,2001,7(3):53-57. 被引量：1
-
4张彦明,赵学红,张东峰.放射性肺损伤的多种原因分析[J].中国医药指南,2014,12(32):374-375. 被引量：2
-
5蒋玲,汪燕,刘士侠.急性心肌梗死误诊5例分析[J].浙江临床医学,2009,11(8):860-861.
-
6周月莲,杨健美,张玉霞.急性白血病抗血管新生治疗中的护理[J].山东医药,2003,43(8):9-11. 被引量：1
-
7于果.抗血管新生治疗在血液肿瘤治疗中的应用效果评价[J].中国医药指南,2015,13(34):108-109. 被引量：2
-
8邢飞虹,修瑞娟.VEGF及依据VEGF发展的肿瘤治疗新进展[J].国外医学（生理病理科学与临床分册）,2003,23(4):358-361. 被引量：1
-
9都伟丽,吴晴,王理伟.抗肿瘤血管新生疗效评价以及相关抵抗性生物标志物[J].临床肿瘤学杂志,2010,15(5):472-476. 被引量：4
-
10徐媛媛.抗血管新生治疗在血液肿瘤治疗中的应用[J].中国医药指南,2014,12(25):83-84. 被引量：1
